Home/Filings/4/0001209191-21-017523
4//SEC Filing

Edwards Thomas A. 4

Accession 0001209191-21-017523

CIK 0001340652other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:33 PM ET

Size

6.6 KB

Accession

0001209191-21-017523

Insider Transaction Report

Form 4
Period: 2021-03-02
Transactions
  • Sale

    Common Stock

    2021-03-02$70.08/sh600$42,048119,857 total
  • Sale

    Common Stock

    2021-03-02$70.03/sh500$35,015120,457 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $70.03 to $70.13 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Issuer

ChemoCentryx, Inc.

CIK 0001340652

Entity typeother

Related Parties

1
  • filerCIK 0001648283

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:33 PM ET
Size
6.6 KB